, , , ,

Two major Alzheimer’s clinical trials will soon begin enrolling participants — the Insulin Study (also know as SNIFF) and the so-called A-4 Trial.

Join USAgainstAlzheimer’s on Thursday, February 6 from 12-1pm ET for the next Activists Network conference call to hear Dr. Suzanne Craft of Wake Forest Medical School, who is the director of the Insulin Study (SNIFF). This study will examine whether a type of insulin, when administered as a nasal spray, improves memory in adults with a mild memory impairment or mild Alzheimer’s disease. Dr. Craft will explain SNIFF and answer your general trial questions, including who is eligible, study locations and how to sign up. Enrollment is scheduled to begin in the coming weeks.

To register for this call please go to: http://actions.usagainstalzheimers.org/p/salsa/web/common/public/signup?signup_page_KEY=8587.

Ginny Biggar at USAgainstAlzheimer’s can answer any questions you have. Her email is vbiggar[at]usagainstalzheimers.org.